Merck Receives Patent for CRISPR Technology in China

  • Author: ChemistryViews.org
  • Published: 24 April 2018
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Merck
  • Associated Suppliers: Merck KGaA, Darmstadt, Germany
thumbnail image: Merck Receives Patent for CRISPR Technology in China

Merck announced that the Chinese Patent Office (State Intellectual Property Office of the People's Republic of China - SIPO;中华人民共和国国家知识产权局) has granted Merck’s patent application for the company’s CRISPR technology. The patent covers integration of an external DNA sequence into the chromosome of eukaryotic cells such as mammalian and plant cells. This allows to replace a disease-associated mutation with a beneficial or functional sequence. The method is of great interest for creating disease models and gene therapy and can be used to insert transgenes that label endogenous proteins for visual tracking within cells.

Merck has a 13-year history in the genome-editing field. The company has related patent filings for its insertion CRISPR method in the U.S., Brazil, India, and Japan. Similar key patents have been granted in Australia, Canada, Europe, Israel, Singapore, and South Korea.

To supports research with genome editing under careful consideration of ethical and legal standards, Merck has established a Bioethics Advisory Panel to give guidance for research in which its businesses are involved, including research on or using genome editing. The company has defined a clear operational position taking into account scientific and societal issues while not blocking any promising therapeutic approaches for use in research and applications.


 

Article Views: 566

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH